$STXS

Stereotaxis, Inc.

CIK:0001289340|SEC Filings

Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Revenue:
Total revenue	$ 7,670	$ 8,798	$ 13,961	$ 16,270
Cost of revenue:
Total cost of revenue	3,184	4,219	5,681	7,627
Gross margin	4,486	4,579	8,280	8,643
Operating expenses:
Research and development	2,390	1,777	4,787	4,127
Sales and marketing	2,595	3,269	5,212	6,417
General and administrative	4,069	4,002	8,830	8,497
Other		(492)		(492)
Total operating expenses	9,054	8,556	18,829	18,549
Operating loss	(4,568)	(3,977)	(10,549)	(9,906)
Other income		(1)	(5)	(1)
Interest income, net	100	152	225	258
Net loss	(4,468)	(3,826)	(10,329)	(9,649)
Cumulative dividend on convertible preferred stock	(314)	(318)	(625)	(632)
Net loss attributable to common stockholders	$ (4,782)	$ (4,144)	$ (10,954)	$ (10,281)
Net loss per share attributable to common stockholders:
Basic	$ (0.05)	$ (0.05)	$ (0.11)	$ (0.12)
Diluted	$ (0.05)	$ (0.05)	$ (0.11)	$ (0.12)
Weighted average number of common shares and equivalents:
Basic	100,031,760	87,952,086	99,496,942	87,861,231
Diluted	100,031,760	87,952,086	99,496,942	87,861,231
Systems [Member]
Revenue:
Total revenue	$ 1,479	$ 3,038	$ 2,798	$ 5,002
Cost of revenue:
Total cost of revenue	1,057	2,366	1,861	4,033
Disposables Service and Accessories [Member]
Revenue:
Total revenue	6,191	5,760	11,163	11,268
Cost of revenue:
Total cost of revenue	$ 2,127	$ 1,853	$ 3,820	$ 3,594

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities
Net loss	$ (10,329)	$ (9,649)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation	330	312
Amortization of intangibles	472	459
Loss on revaluation of contingent consideration	1,398	458
Non-cash lease expense	(9)	1
Stock-based compensation	3,718	4,902
Changes in operating assets and liabilities:
Accounts receivable	(621)	(569)
Inventories	(2,953)	(1,277)
Prepaid expenses and other current assets	(413)	913
Other assets	(57)	(11)
Accounts payable	2,004	1,062
Accrued liabilities	(740)	(145)
Deferred revenue	83	(1,968)
Net cash used in operating activities	(7,117)	(5,512)
Cash flows from investing activities
Purchase of property and equipment	(143)	(23)
Interim financing provided to Robocath	(1,081)
Net cash used by investing activities	(1,224)	(23)
Cash flows from financing activities
Proceeds from issuance of stock	5,624	66
Equity issuance costs	(213)
Net cash provided by financing activities	5,411	66
Net decrease in cash and cash equivalents	(2,930)	(5,469)
Cash and cash equivalents at beginning of period	13,421	12,436
Cash and cash equivalents at end of period	10,491	6,967
Supplemental disclosure of cash flow information:
Purchase of property and equipment included in accounts payable	49
Equity issuance costs included in accounts payable	$ 45

Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 10,491	$ 13,421
Accounts receivable, net of allowance of $594 and $541 at 2026 and 2025, respectively	7,549	5,847
Insurance receivable	6,316	4,316
Inventories, net	12,520	9,567
Prepaid expenses and other current assets	1,111	698
Total current assets	37,987	33,849
Property and equipment, net	2,881	3,019
Goodwill	3,764	3,764
Intangible assets, net	5,957	6,429
Operating lease right-of-use assets	4,658	4,912
Prepaid and other non-current assets	335	278
Total assets	55,582	52,251
Current liabilities:
Accounts payable	6,866	4,768
Accrued liabilities	1,325	2,065
Accrued legal liabilities	6,316	4,316
Deferred revenue	5,928	5,675
Current contingent consideration	5,673	4,894
Current portion of operating lease liabilities	689	642
Total current liabilities	26,797	22,360
Long-term deferred revenue	384	555
Long-term contingent consideration	5,343	4,724
Operating lease liabilities	4,484	4,794
Other liabilities	1,097	1,097
Total liabilities	38,105	33,530
Stockholders’ equity:
Common stock, par value $0.001; 300,000,000 shares authorized, 97,938,091 and 95,339,628 shares issued at 2026 and 2025, respectively	98	95
Additional paid in capital	606,048	596,960
Treasury stock, 4,015 shares at 2026 and 2025	(206)	(206)
Accumulated deficit	(593,697)	(583,368)
Total stockholders’ equity	12,243	13,481
Total liabilities and stockholders’ equity	55,582	52,251
Convertible Preferred Stock Series A [Member]
Series A - Convertible preferred stock:
Convertible preferred stock, Series A, par value $0.001; 10,000,000 shares authorized; 20,983 and 21,008 shares outstanding at 2026 and 2025, respectively	$ 5,234	$ 5,240